[{"NetIncomeLoss_1_Q2_USD":-9264233.0,"ProceedsFromRepaymentsOfRelatedPartyDebt_2_Q2_USD":91306.0,"RepaymentsOfRelatedPartyDebt_2_Q2_USD":136833.0,"TemporaryEquitySharesOutstanding_0_Q2_shares":27600000.0,"AssetsCurrent_0_Q2_USD":1762340.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":1566177.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-276000000.0,"OperatingCostsAndExpenses_1_Q2_USD":1752783.0,"OperatingCostsAndExpenses_2_Q2_USD":2974830.0,"CommitmentsAndContingencies_0_Q2_USD":null,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"ProceedsFromRelatedPartyDebt_2_Q2_USD":1000000.0,"DueToRelatedPartiesCurrent_0_Q2_USD":988400.0,"Liabilities_0_Q2_USD":33250310.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":1345945.0,"FairValueAdjustmentOfWarrants_1_Q2_USD":7533067.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":4406133.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":401506.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":278552967.0,"AssetsHeldInTrustNoncurrent_0_Q2_USD":276020334.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q2_USD":1345945.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":1564527.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-7511450.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-4374199.0,"PrepaidExpenseCurrent_0_Q2_USD":416395.0,"Cash_0_Q2_USD":1345945.0,"ProceedsFromInterestReceived_2_Q2_USD":0.0,"Assets_0_Q2_USD":277782674.0,"UnrealizedGainLossOnInvestments_2_Q2_USD":4595.0,"NetIncomeLoss_2_Q2_USD":-7349029.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"AdditionalPaidInCapital_0_Q2_USD":0.0,"LiabilitiesCurrent_0_Q2_USD":2554577.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-1207022.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q2_USD":0.0,"MarketableSecuritiesUnrealizedGainLoss_2_Q2_USD":4595.0,"PaymentsToAcquireRestrictedInvestments_2_Q2_USD":276000000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-31468326.0,"StockholdersEquity_0_Q2_USD":-31467636.0,"ProfitLoss_1_Q2_USD":-9264233.0,"ProfitLoss_2_Q2_USD":-7349029.0,"CashFDICInsuredAmount_0_Q2_USD":250000.0,"SharePrice_0_Q2_USD":10.0,"ProceedsFromIssuanceOfWarrants_2_Q2_USD":7520000.0,"PreferredStockSharesAuthorized_0_Q2_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":277782674.0,"PreferredStockValue_0_Q2_USD":null,"InvestmentIncomeInterest_1_Q2_USD":10017.0,"InvestmentIncomeInterest_2_Q2_USD":15739.0,"OperatingIncomeLoss_1_Q2_USD":-1752783.0,"OperatingIncomeLoss_2_Q2_USD":-2974830.0,"RedeemableNoncontrollingInterestEquityCommonCarryingAmount_0_Q2_USD":276000000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":270480000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":416395.0,"LiabilitiesAssumed1_2_Q2_USD":9660000.0,"Ticker":"PEAR","CIK":"1835567","name":"THIMBLE POINT ACQUISITION CORP.","OfficialName":"Pear Therapeutics Inc. Class A Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"621640486.0","Country":"United States","Sector":"Technology","Industry":"Computer Software: Prepackaged Software","Market":"NASDAQ","SP500":"nan","filed":"20210819"}]